AGMT_MM-1: Assessing the oral microbiome in patients with relapsed/refractory multiple myeloma

Investigating KRd versus KTd in NDMM patients with high-risk cytogenetics

GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma

CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma

CANDOR updated results: KdD versus Kd in patients with RRMM according to prior lines of therapy

Patient reported outcomes for the CANDOR trial for multiple myeloma

Reducing damage to swallowing muscles during radiotherapy for head and neck cancers

Updated results from KEYNOTE-426 for metastatic kidney cancer

HCRN GU16-260: Nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with advanced renal cell carcinoma

Comment: JAVELIN-100 for metastatic urothelial cancer

3-weekly cisplatin or weekly cisplatin for squamous cell carcinoma of head and neck

ASCO 2020: Breast cancer roundup